Works matching IS 00071048 AND DT 2018 AND VI 183 AND IP 2

Results: 26

Pulmonary toxicity in paediatric patients with relapsed or refractory Hodgkin lymphoma receiving brentuximab vedotin.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 251, doi. 10.1111/bjh.15586

By:

Faulk, Kelly E.;
Sopfe, Jenna M.;
Campbell, Kristen;
Liptzin, Deborah R.;
Liu, Arthur K.;
Franklin, Anna R. K.;
Cost, Carrye R.

Publication type:

Article

The MCL35 gene expression proliferation assay predicts high‐risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 225, doi. 10.1111/bjh.15518

By:

Holte, Harald;
Beiske, Klaus;
Boyle, Merrill;
Trøen, Gunhild;
Blaker, Yngvild N.;
Myklebust, June;
Kvaløy, Sunniva;
Rosenwald, Andreas;
Lingjærde, Ole C.;
Rimsza, Lisa M.;
Smeland, Erlend B.;
Scott, David W.;
Kolstad, Arne

Publication type:

Article

Ibrutinib induces rapid down‐regulation of inflammatory markers and altered transcription of chronic lymphocytic leukaemia‐related genes in blood and lymph nodes.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 212, doi. 10.1111/bjh.15516

By:

Palma, Marzia;
Krstic, Aleksandra;
Peña Perez, Lucia;
Berglöf, Anna;
Meinke, Stephan;
Wang, Qing;
Blomberg, K. Emelie M.;
Kamali‐Moghaddam, Masood;
Shen, Qiujin;
Jaremko, Georg;
Lundin, Jeanette;
De Paepe, Ayla;
Höglund, Petter;
Kimby, Eva;
Österborg, Anders;
Månsson, Robert;
Smith, C. I. Edvard

Publication type:

Article

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 196, doi. 10.1111/bjh.15515

By:

Paulus, Aneel;
Manna, Alak;
Akhtar, Sharoon;
Paulus, Shumail M.;
Sharma, Mayank;
Coignet, Marie V.;
Jiang, Liuyan;
Roy, Vivek;
Witzig, Thomas E.;
Ansell, Stephen M.;
Allan, John;
Furman, Richard;
Aulakh, Sonikpreet;
Manochakian, Rami;
Ailawadhi, Sikander;
Chanan‐Khan, Asher A.;
Sher, Taimur

Publication type:

Article

"Faggot" neutrophils in acute promyelocytic leukaemia with ongoing tretinoin therapy.

Published in:

2018

By:

Ma, Shuang;
Yang, Lian‐He;
Luedke, Catherine;
Ingersoll, Kimberly;
Wang, Endi

Publication type:

Case Study

von Willebrand factor clearance – biological mechanisms and clinical significance.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 185, doi. 10.1111/bjh.15565

By:

O'Sullivan, Jamie M.;
Ward, Soracha;
Lavin, Michelle;
O'Donnell, James S.

Publication type:

Article

SLC2A5 overexpression in childhood philadelphia chromosome‐positive acute lymphoblastic leukaemia.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 242, doi. 10.1111/bjh.15580

By:

Zhao, Pan;
Huang, Jingcao;
Zhang, Dan;
Zhang, Danfeng;
Wang, Fangfang;
Qu, Ying;
Guo, Tingting;
Qin, Yu;
Wei, Jin;
Niu, Ting;
Zheng, Yuhuan

Publication type:

Article

The use of direct oral anticoagulants in chronic kidney disease.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 170, doi. 10.1111/bjh.15564

By:

Parker, Kathrine;
Thachil, Jecko

Publication type:

Article

Diagnosis of pulmonary embolism: should we wait YEARS?

Published in:

2018

By:

Alikhan, Raza;
Roberts, Heledd

Publication type:

Editorial

Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17‐10 CIARA trial).

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 235, doi. 10.1111/bjh.15546

By:

Krauter, Jürgen;
Fiedler, Walter;
Schlenk, Richard F.;
Paschka, Peter;
Thol, Felicitas;
Lübbert, Michael;
Wattad, Mohammed;
Verbeek, Mareike;
Könecke, Christian;
Neuhaus, Barbara;
Papkalla, Armin;
Kebenko, Maxim;
Janning, Melanie;
Döhner, Konstanze;
Gaidzik, Verena I.;
Becker, Heiko;
Greil, Christine;
Reimer, Peter;
Götze, Katharina S.;
Döhner, Hartmut

Publication type:

Article

ACS in children with sickle cell anaemia in Uganda: prevalence, presentation and aetiology.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 289, doi. 10.1111/bjh.15543

By:

Ochaya, Odong;
Hume, Heather;
Bugeza, Sam;
Bwanga, Freddie;
Byanyima, Rosemary;
Kisembo, Harriet;
Tumwine, James K.

Publication type:

Article

ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 276, doi. 10.1111/bjh.15531

By:

Faleschini, Michela;
Melazzini, Federica;
Marconi, Caterina;
Giangregorio, Tania;
Pippucci, Tommaso;
Cigalini, Elena;
Pecci, Alessandro;
Bottega, Roberta;
Ramenghi, Ugo;
Siitonen, Timo;
Seri, Marco;
Pastore, Annalisa;
Savoia, Anna;
Noris, Patrizia

Publication type:

Article

Idiopathic pulmonary arterial hypertension – a unrecognized cause of high‐shear high‐flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 267, doi. 10.1111/bjh.15530

By:

Pelland‐Marcotte, Marie‐Claude;
Humpl, Tilman;
James, Paula D.;
Rand, Margaret L.;
Bouskill, Vanessa;
Reyes, Janette T.;
Bowman, Mackenzie L.;
Carcao, Manuel D.

Publication type:

Article

Emicizumab‐mediated haemostatic function in patients with haemophilia A is down‐regulated by activated protein C through inactivation of activated factor V.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 257, doi. 10.1111/bjh.15525

By:

Yada, Koji;
Nogami, Keiji;
Shinozawa, Keiko;
Kitazawa, Takehisa;
Hattori, Kunihiro;
Amano, Kagehiro;
Fukutake, Katsuyuki;
Shima, Midori

Publication type:

Article

Relative potency of the thrombopoietin receptor agonists eltrombopag, avatrombopag and romiplostim in a patient with chronic immune thrombocytopenia.

Published in:

2018

By:

Al‐Samkari, Hanny;
Kuter, David J.

Publication type:

Case Study

Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 310, doi. 10.1111/bjh.14958

By:

How, Joan;
Trinkaus, Kathryn M.;
Oh, Stephen T.

Publication type:

Article

Intracranial vasculopathy and infarct recurrence in children with sickle cell anaemia, silent cerebral infarcts and normal transcranial Doppler velocities.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 324, doi. 10.1111/bjh.14979

By:

Choudhury, Natasha A.;
DeBaun, Michael R.;
Ponisio, Maria R.;
Jordan, Lori C.;
Rodeghier, Mark;
Pruthi, Sumit;
McKinstry, Robert C.

Publication type:

Article

Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 319, doi. 10.1111/bjh.14977

By:

Grodzielski, Matías;
Di Buduo, Christian A.;
Goette, Nora P.;
Lev, Paola R.;
Soprano, Paolo M.;
Heller, Paula G.;
Balduini, Alessandra;
Marta, Rosana F.

Publication type:

Article

Familial acquired thrombotic thrombocytopenic purpura: immunogenetic link with HLA‐DRB111 and DQB103 antigens.

Published in:

2018

By:

Lombardi, Anna M.;
Pulini, Stefano;
Passeri, Cecilia;
Iuliani, Ornella;
Salutari, Prassede;
Businaro, Antonia;
Fabris, Fabrizio;
Vianello, Fabrizio

Publication type:

Case Study

Elimination of different leukaemia subtypes using novel CD89‐specific human cytolytic fusion proteins.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 313, doi. 10.1111/bjh.14971

By:

Gresch, Gerrit;
Schenke, Lea;
Mladenov, Radoslav;
Zwirner, Stefan;
Cremer, Christian;
Niesen, Judith;
Grieger, Elena;
Brümmendorf, Tim;
Jost, Edgar;
Fischer, Rainer;
Stockmeyer, Bernhard;
Barth, Stefan;
Nachreiner, Thomas;
Stein, Christoph

Publication type:

Article

Clinical significance of SH2B3 (LNK) expression in paediatric B‐cell precursor acute lymphoblastic leukaemia.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 327, doi. 10.1111/bjh.14981

By:

Yano, Mio;
Imamura, Toshihiko;
Asai, Daisuke;
Deguchi, Takao;
Hashii, Yoshiko;
Endo, Mikiya;
Sato, Atsushi;
Kawasaki, Hirohide;
Kosaka, Yoshiyuki;
Kato, Koji;
Hori, Hiroki;
Yumura‐Yagi, Keiko;
Hara, Junichi;
Oda, Megumi;
Horibe, Keizo

Publication type:

Article

An acquired NRAS mutation contributes to neutrophilic progression in a patient with primary myelofibrosis.

Published in:

2018

By:

Langabeer, Stephen E.;
Haslam, Karl;
Groarke, Emma;
Conneally, Eibhlin

Publication type:

Case Study

Understanding patterns and correlates of daily pain using the Sickle cell disease Mobile Application to Record Symptoms via Technology (SMART).

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 306, doi. 10.1111/bjh.14956

By:

Jonassaint, Charles R.;
Kang, Chaeryon;
Abrams, Daniel M.;
Li, Jingyi J.;
Mao, Jason;
Jia, Yimeng;
Long, Qi;
Sanger, Maureen;
Jonassaint, Jude C.;
De Castro, Laura;
Shah, Nirmish

Publication type:

Article

"Haemochromatotic" characteristics of the human BEL‐7402 cell line.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 302, doi. 10.1111/bjh.14952

By:

Xu, Anjian;
Li, Yanmeng;
Chen, Wei;
Li, Xiaojin;
Zhang, Wei;
Li, Siwen;
Wu, Lina;
Wu, Zhen;
Zhang, Bei;
Ou, Xiaojuan;
Huang, Jian

Publication type:

Article

A three‐miRNA‐based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1‐RUNX1T1 acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2018, v. 183, n. 2, p. 298, doi. 10.1111/bjh.14950

By:

Zampini, Matteo;
Bisio, Valeria;
Leszl, Anna;
Putti, Maria C.;
Menna, Giuseppe;
Rizzari, Carmelo;
Pession, Andrea;
Locatelli, Franco;
Basso, Giuseppe;
Tregnago, Claudia;
Pigazzi, Martina

Publication type:

Article

Issue Information.

Published in:: British Journal of Haematology, 2018, v. 183, n. 2, p. 157, doi. 10.1111/bjh.14944
Publication type:: Article